Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEVICONTROL-2
DRKS00003449Phase 4Completed
- Sponsor
- IPPMed
- Start
- Jan 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of candesartan, olmesartan and amlodipine in hypertension (HTN), sponsored by IPPMed. Started Jan 2012; status: completed.
02
Drugs
candesartanolmesartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on DRKS00003449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00003449.